tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LENZ Stock Latest News

Lenz Therapeutics announces MFDS submission of NDA for LNZ100
The FlyLenz Therapeutics announces MFDS submission of NDA for LNZ100
8h ago
LENZ
3 Best Stocks to Buy Now, 12/1/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 12/1/2025, According to Top Analysts
9h ago
KTOS
LENZ
LENZ Therapeutics: Strategic Marketing and Strong Financials Signal a Compelling Buy Opportunity
PremiumRatings
LENZ Therapeutics: Strategic Marketing and Strong Financials Signal a Compelling Buy Opportunity
16d ago
LENZ
LENZ Therapeutics Reports Strong Launch of VIZZ Eye Drop
PremiumCompany Announcements
LENZ Therapeutics Reports Strong Launch of VIZZ Eye Drop
26d ago
LENZ
Lenz Therapeutics’ Earnings Call Highlights VIZZ Success
PremiumCompany Announcements
Lenz Therapeutics’ Earnings Call Highlights VIZZ Success
26d ago
LENZ
Promising Launch of LENZ Therapeutics’ VIZZ: A Buy Opportunity Amidst Strong Initial Performance and Market Enthusiasm
PremiumRatingsPromising Launch of LENZ Therapeutics’ VIZZ: A Buy Opportunity Amidst Strong Initial Performance and Market Enthusiasm
26d ago
LENZ
Lenz Therapeutics reports Q3 EPS (59c), consensus (69c)
Premium
The Fly
Lenz Therapeutics reports Q3 EPS (59c), consensus (69c)
26d ago
LENZ
Positive Outlook on LENZ Therapeutics’ VIZZ Eye Drop Launch Drives Buy Rating
Premium
Ratings
Positive Outlook on LENZ Therapeutics’ VIZZ Eye Drop Launch Drives Buy Rating
1M ago
LENZ
Short Report: Bears pare exposure to Beyond Meat, add to Krispy Kreme
PremiumThe Fly
Short Report: Bears pare exposure to Beyond Meat, add to Krispy Kreme
1M ago
NNE
BYND
Lenz Therapeutics price target raised to $67 from $51 at Piper Sandler
PremiumThe Fly
Lenz Therapeutics price target raised to $67 from $51 at Piper Sandler
2M ago
LENZ
LENZ Therapeutics Raises $80M Through Stock Sale
PremiumCompany Announcements
LENZ Therapeutics Raises $80M Through Stock Sale
2M ago
8K
LENZ
Short Report: TeraWulf short interest at record high despite stock strength
PremiumThe Fly
Short Report: TeraWulf short interest at record high despite stock strength
2M ago
RH
RKT
LENZ Therapeutics: Buy Rating Affirmed Amid Successful Early Launch of Vizz and Promising Market Potential
PremiumRatingsLENZ Therapeutics: Buy Rating Affirmed Amid Successful Early Launch of Vizz and Promising Market Potential
2M ago
LENZ
LENZ Therapeutics Launches FDA-Approved Presbyopia Eye Drop
Premium
Company Announcements
LENZ Therapeutics Launches FDA-Approved Presbyopia Eye Drop
2M ago
8K
LENZ
Lenz Therapeutics announces U.S. commercial availability of VIZZ
Premium
The Fly
Lenz Therapeutics announces U.S. commercial availability of VIZZ
2M ago
LENZ
Lenz Therapeutics announces availability of VIZZ in U.S.
PremiumThe Fly
Lenz Therapeutics announces availability of VIZZ in U.S.
2M ago
LENZ
Strong Buy Recommendation for LENZ Therapeutics: Early Approval and Strategic Launch of VIZZ Eye Drops
PremiumRatings
Strong Buy Recommendation for LENZ Therapeutics: Early Approval and Strategic Launch of VIZZ Eye Drops
4M ago
LENZ
Lenz Therapeutics price target raised to $53 from $44 at BofA
PremiumThe Fly
Lenz Therapeutics price target raised to $53 from $44 at BofA
4M ago
LENZ
Lenz Therapeutics price target raised to $56 from $48 at H.C. Wainwright
PremiumThe Fly
Lenz Therapeutics price target raised to $56 from $48 at H.C. Wainwright
4M ago
LENZ
Buy Rating for LENZ Therapeutics: Vizz’s Early FDA Approval and Market Differentiation Drive Growth Potential
PremiumRatingsBuy Rating for LENZ Therapeutics: Vizz’s Early FDA Approval and Market Differentiation Drive Growth Potential
4M ago
LENZ
Lenz Therapeutics price target raised to $52 from $49 at Citi
Premium
The Fly
Lenz Therapeutics price target raised to $52 from $49 at Citi
4M ago
LENZ
LENZ Therapeutics Gains FDA Approval for VIZZ Eye Drop
Premium
Company Announcements
LENZ Therapeutics Gains FDA Approval for VIZZ Eye Drop
4M ago
8K
LENZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >